STAB1 and atherosclerosis: Double‐knockout mice (Stab‐DKO) develop impaired kidney function and a decreased lifespan, while single Stabilin deficiency or therapeutic inhibition ameliorates atherosclerosis and Stab1‐inhibition is subject of clinical trials in immuno‐oncology.